Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02636127
What this trial is testing

Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
Assistance Publique Hopitaux De Marseille 30
Early research (Phase 1)Study completedNCT01333046
What this trial is testing

Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL

Who this might be right for
Hodgkin LymphomaNon-Hodgkin LymphomaHodgkin Disease
Baylor College of Medicine 36
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03393962
What this trial is testing

Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors

Who this might be right for
Ovarian Cancer
Shenzhen Geno-Immune Medical Institute 20
Early research (Phase 1)Study completedNCT01144247
What this trial is testing

Cellular Immunotherapy Study for Brain Cancer

Who this might be right for
GliomasAnaplastic AstrocytomaAnaplastic Oligodendroglioma+3 more
Jonsson Comprehensive Cancer Center 10
Early research (Phase 1)Study completedNCT00000756
What this trial is testing

Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 15
Early research (Phase 1)Active Not RecruitingNCT07000149
What this trial is testing

Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma
AstraZeneca 9
Testing effectiveness (Phase 2)Ended earlyNCT00808080
What this trial is testing

A Clinical Trial of Cytotoxic T Cells Augmenting Autologous Hematopoietic Stem Cell (AHSC) Transplantation for Acute Myeloid Leukemia (AML)

Who this might be right for
AML
Thomas A. Lane, MD 6
Early research (Phase 1)Study completedNCT03281382
What this trial is testing

Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Henry Ford Health System 12
Testing effectiveness (Phase 2)Study completedNCT04305054
What this trial is testing

Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 335
Early research (Phase 1)Study completedNCT02588105
What this trial is testing

Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer

Who this might be right for
Advanced Solid Tumours
AstraZeneca 84
Not applicableStudy completedNCT04531319
What this trial is testing

Immune Cell Subgroups in Covid 19 Patients

Who this might be right for
Covid19
Istanbul Training and Research Hospital 50
Early research (Phase 1)UnknownNCT04126590
What this trial is testing

Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
Changchun Intellicrown Pharmaceutical Co. LTD 39
Early research (Phase 1)Study completedNCT00076180
What this trial is testing

Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocytic LeukemiaLeukemia, T-Cell Large Granular Lymphocytic
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Looking for participantsNCT04197596
What this trial is testing

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Who this might be right for
Viral InfectionPrimary Immune Deficiency Disorder
New York Medical College 40
Early research (Phase 1)Ended earlyNCT01274377
What this trial is testing

Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT

Who this might be right for
Cytomegalovirus Infections
Nelson Chao 5
Not applicableStudy completedNCT00516945
What this trial is testing

Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers

Who this might be right for
Hepatitis BNeoplasms
Hospital Authority, Hong Kong 110
Early research (Phase 1)WithdrawnNCT05738161
What this trial is testing

Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma

Who this might be right for
Advanced Urothelial Carcinoma
Insel Gruppe AG, University Hospital Bern
Large-scale testing (Phase 3)Study completedNCT02578641
What this trial is testing

A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients

Who this might be right for
Nasopharyngeal Carcinoma
Tessa Therapeutics 330
Early research (Phase 1)Looking for participantsNCT05292664
What this trial is testing

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Who this might be right for
Myelodysplastic Syndromes, de NovoMyelodysplastic Syndromes, SecondaryMyelodysplastic Syndromes, Previously Treated+8 more
Andrew E. Place, MD 30
Large-scale testing (Phase 3)Study completedNCT05492409
What this trial is testing

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Next Page